A new study from Oregon Health & Science University has uncovered how small molecules within bacteria interact with proteins, ...

Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups ...

Nobel Prize winner Demis Hassabis thinks human trials will happen soon Clinical trials of the first drugs designed with the ...

"Real-time analytics is more than just a tool—it’s a paradigm shift," says Dr. Aditya Dodda, an expert in building real-time ...

With the use of deep learning and advanced algorithms, generative AI can promote acceleration in the design and development ...

The proof-of-concept demonstrates the power of pairing AI with lab orchestration solutions to automate molecular screening ...

The AI in Drug Discovery Market is experiencing substantial expansion, boosted by AI-powered innovations in drug optimization, repurposing, and preclinical testing.Pune, Jan. 13, 2025 (GLOBE NEWSWIRE) ...

The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

Findings from a large-scale review indicate certain medications may influence dementia risk, offering insights for prevention ...

With the advent of machine learning and artificial intelligence, materials science could be poised to take its next big leap ...

Needham analyst has initiated coverage on Absci Corporation (NASDAQ:ABSI), a drug and target discovery company that harnesses ...

GUILFORD, Conn., Jan. 13, 2025 (GLOBE NEWSWIRE) -- InveniAI LLC, a global leader in the application of artificial intelligence (AI), machine learning (ML), and generative AI tools to revolutionize ...